David Fitzgerald

David Fitzgerald

Partner

David has over twenty years of experience managing private equity and venture capital partnerships & investing in high growth companies. David’s primary focus has been on the healthcare, information technology and business services sectors. Prior to joining Petra, David was a General Partner at Richland Ventures, a venture capital fund with $340 million in assets under management. Earlier in his career, David led market development and acquisition activities for InformDx, a diagnostic laboratory company and THG Management Services, a managed healthcare company.

David has board-level experience with many successful growth companies including: SpecialtyCare (sold to American Securities), US Healthworks (sold to Dignity Health), Televox (sold to West Corp.), Appriss (sold to Bain Capital), Synhrgy (sold to Mercer), Nuvox Communications (sold to Windstream), Salveo Specialty Pharmacy (sold to Catamaran), New Century Hospice (sold to Curo Health Services), Opportune IT (sold to Streamline Health), and VirMedica (sold to CareMetx).

He currently serves as a director on the boards of Urgent Team, SUN Behavioral Health, Clinipace, Lineagen, Remita Health, Alternative Behavior Strategies and Etairos Health.

David received a B.A. degree from Washington & Lee University.